144 related articles for article (PubMed ID: 25124939)
21. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
[TBL] [Abstract][Full Text] [Related]
22. PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study.
Siller G; Gebauer K; Welburn P; Katsamas J; Ogbourne SM
Australas J Dermatol; 2009 Feb; 50(1):16-22. PubMed ID: 19178487
[TBL] [Abstract][Full Text] [Related]
23. A seamless phase I/II dose-finding trial assessing ingenol disoxate (LEO 43204) for field treatment of actinic keratosis on the scalp.
Weiss J; Ulrich M; Bukhalo M; Østerdal ML; Bang B; Hanke CW
Br J Dermatol; 2017 Jun; 176(6):1456-1464. PubMed ID: 28078678
[TBL] [Abstract][Full Text] [Related]
24. Oleogel-S10 in Dystrophic Epidermolysis Bullosa: A Case Series Evaluating the Impact on Wound Burden Over Two Years.
Torres Pradilla M; Álvarez E; Novoa M; Lozano I; Trujillo M
Adv Ther; 2024 Feb; 41(2):867-877. PubMed ID: 38170434
[TBL] [Abstract][Full Text] [Related]
25. Accelerated reepithelialization by triterpenes: proof of concept in the healing of surgical skin lesions.
Metelmann HR; Brandner JM; Schumann H; Bross F; Fimmers R; Böttger K; Scheffler A; Podmelle F
Skin Pharmacol Physiol; 2015; 28(1):1-11. PubMed ID: 25034442
[TBL] [Abstract][Full Text] [Related]
26. Topical vitamin B12--a new therapeutic approach in atopic dermatitis-evaluation of efficacy and tolerability in a randomized placebo-controlled multicentre clinical trial.
Stücker M; Pieck C; Stoerb C; Niedner R; Hartung J; Altmeyer P
Br J Dermatol; 2004 May; 150(5):977-83. PubMed ID: 15149512
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of ingenol mebutate 0.015% gel 3 weeks after cryosurgery of actinic keratosis: 11-week results.
Berman B; Goldenberg G; Hanke CW; Tyring SK; Werschler WP; Knudsen KM; Goncalves J; Larsson T; Skov T; Swanson N
J Drugs Dermatol; 2014 Feb; 13(2):154-60. PubMed ID: 24509965
[TBL] [Abstract][Full Text] [Related]
28. Open label randomized study comparing 3 months vs. 6 months treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronic acid gel: a trial of the German Dermatologic Cooperative Oncology Group.
Pflugfelder A; Welter AK; Leiter U; Weide B; Held L; Eigentler TK; Dirschka T; Stockfleth E; Nashan D; Garbe C;
J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):48-53. PubMed ID: 21414035
[TBL] [Abstract][Full Text] [Related]
29. Recurrence rates and patient assessed outcomes of 0.5% 5-fluorouracil in combination with salicylic acid treating actinic keratoses.
Stockfleth E; Zwingers T; Willers C
Eur J Dermatol; 2012; 22(3):370-4. PubMed ID: 22494856
[TBL] [Abstract][Full Text] [Related]
30. A multicenter, randomized, vehicle-controlled phase 2 study of blue light photodynamic therapy with aminolevulinic acid HCl 20% topical solution for the treatment of actinic keratoses on the upper extremities: the effect of occlusion during the drug incubation period.
Schmieder GJ; Huang EY; Jarratt M
J Drugs Dermatol; 2012 Dec; 11(12):1483-9. PubMed ID: 23377520
[TBL] [Abstract][Full Text] [Related]
31. Histological examination confirms clinical clearance of actinic keratoses following treatment with ingenol mebutate 0·05% gel.
Ulrich M; Reinhold U; Skov T; Elvang Søndergaard R; Guitera P
Br J Dermatol; 2017 Jan; 176(1):71-80. PubMed ID: 27518593
[TBL] [Abstract][Full Text] [Related]
32. Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies.
Hauschild A; Stockfleth E; Popp G; Borrosch F; Brüning H; Dominicus R; Mensing H; Reinhold U; Reich K; Moor AC; Stocker M; Ortland C; Brunnert M; Szeimies RM
Br J Dermatol; 2009 May; 160(5):1066-74. PubMed ID: 19222455
[TBL] [Abstract][Full Text] [Related]
33. Topical resiquimod dosing regimens in patients with multiple actinic keratoses: a multicentre, partly placebo-controlled, double-blind clinical trial.
Stockfleth E; Hofbauer GFL; Reinhold U; Popp G; Hengge UR; Szeimies RM; Brüning H; Anliker M; Hunger T; Dummer R; Ulrich C; Kenzelmann R; Surber C; French LE
Br J Dermatol; 2019 Feb; 180(2):297-305. PubMed ID: 30171698
[TBL] [Abstract][Full Text] [Related]
34. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles.
Swanson N; Abramovits W; Berman B; Kulp J; Rigel DS; Levy S
J Am Acad Dermatol; 2010 Apr; 62(4):582-90. PubMed ID: 20133013
[TBL] [Abstract][Full Text] [Related]
35. Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.
Berman B; Nestor MS; Newburger J; Park H; Swenson N
J Drugs Dermatol; 2014 Nov; 13(11):1353-6. PubMed ID: 25607702
[TBL] [Abstract][Full Text] [Related]
36. Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis.
Anderson L; Schmieder GJ; Werschler WP; Tschen EH; Ling MR; Stough DB; Katsamas J
J Am Acad Dermatol; 2009 Jun; 60(6):934-43. PubMed ID: 19467365
[TBL] [Abstract][Full Text] [Related]
37. Use of ingenol mebutate gel for actinic keratosis in patients in a community dermatology practice.
Bettencourt MS
J Drugs Dermatol; 2014 Mar; 13(3):269-73. PubMed ID: 24595570
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of low-dose 5-fluorouracil/salicylic acid in actinic keratoses in relation to treatment duration.
Szeimies RM; Dirschka T; Prechtl A; Melzer A
J Dtsch Dermatol Ges; 2015 May; 13(5):430-8. PubMed ID: 25918087
[TBL] [Abstract][Full Text] [Related]
39. Effect of retinoid pretreatment on outcomes of patients treated by photodynamic therapy for actinic keratosis of the hand and forearm.
Galitzer BI
J Drugs Dermatol; 2011 Oct; 10(10):1124-32. PubMed ID: 21968662
[TBL] [Abstract][Full Text] [Related]
40. Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: a randomized trial.
Kang S; Goldfarb MT; Weiss JS; Metz RD; Hamilton TA; Voorhees JJ; Griffiths CE
J Am Acad Dermatol; 2003 Jul; 49(1):83-90. PubMed ID: 12833014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]